WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Phase 2

Completed

Conditions: Squamous Cell Carcinoma of the Head and Neck
Carcinoma, Squamous Cell of the Head and Neck
Cancer of Head and Neck
Cancer of the Head and Neck
Head and Neck Cancer
Neoplasms, Head and Neck

Interventions: Drug: nab-Paclitaxel
Biological: Cetuximab
Drug: Cisplatin
Radiation: Intensity-Modulated Radiation Therapy

First Posted Date: 2015-10-09

Last Posted Date: 2024-12-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT02573493

Locations: 🇺🇸
Sanford Cancer Center, Sioux Falls, South Dakota, United States
🇺🇸
The University of Kansas Cancer Center and Medical Pavilion, Westwood, Kansas, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Staph Household Intervention for Eradication (SHINE)

Phase 4

Completed

Conditions: Skin and Subcutaneous Tissue Bacterial Infections
Staphylococcus Aureus
MRSA - Methicillin Resistant Staphylococcus Aureus Infection

Interventions: Drug: Chlorhexidine
Drug: Mupirocin
Behavioral: Household cleaning

First Posted Date: 2015-10-09

Last Posted Date: 2025-04-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 835

Registration Number: NCT02572791

Locations: 🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States
🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)

Phase 1

Withdrawn

Conditions: Myeloproliferative Neoplasm
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndromes
Juvenile Myelomonocytic Leukemia
Atypical Chronic Myeloid Leukemia
Myelofibrosis

Interventions: Drug: Pacritinib
Drug: Decitabine

First Posted Date: 2015-09-30

Last Posted Date: 2017-05-08

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02564536

SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer

Not Applicable

Completed

Conditions: Nonsmall Cell Lung Cancer
Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell-Lung

Interventions: Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30
Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13
Behavioral: Modified Medical Research Council
Behavioral: EQ-5D
Behavioral: Center for Epidemiological Studies Depression Scale
Behavioral: Medical Outcomes Study Social Support Survey

First Posted Date: 2015-09-29

Last Posted Date: 2021-04-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 217

Registration Number: NCT02562027

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Computer-based Neurocognitive Assessment in Children With Central Nervous System Tumors Receiving Proton Beam Radiation Therapy

Recruiting

Conditions: Central Nervous System

Interventions: Other: NIH Toolbox Cognitive Battery

First Posted Date: 2015-09-24

Last Posted Date: 2025-04-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 80

Registration Number: NCT02559752

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Genomic Landscape of Ceritinib

Terminated

Conditions: Carcinoma, Non-Small-Cell Lung
Non-Small Cell Lung Cancer
Non-small Lung Cancer

First Posted Date: 2015-09-18

Last Posted Date: 2018-03-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6

Registration Number: NCT02554591

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Treatment of Chronic Stroke With IpsiHand

Not Applicable

Completed

Conditions: Stroke

Interventions: Device: IpsiHand Device

First Posted Date: 2015-09-17

Last Posted Date: 2018-09-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 23

Registration Number: NCT02552368

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer

Phase 1

Completed

Conditions: Advanced Solid Tumors
Solid Tumors
Pancreatic Cancer

Interventions: Biological: Defactinib
Biological: Pembrolizumab
Drug: Gemcitabine

First Posted Date: 2015-09-11

Last Posted Date: 2021-07-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 43

Registration Number: NCT02546531

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

ED Lung Protective Ventilation to Reduce Complications

Completed

Conditions: Mechanical Ventilation
Ventilator-associated Conditions
ARDS

Interventions: Procedure: lung protective ventilation

First Posted Date: 2015-09-07

Last Posted Date: 2018-12-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1705

Registration Number: NCT02543554

Locations: 🇺🇸
Washinton University School of Medicine in St. Louis, Saint Louis, Missouri, United States

Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors

Phase 1

Withdrawn

Conditions: Carcinoma, Non-Small Cell Lung
Non-Small Cell Lung Cancer
Non-Small-Cell Lung Carcinoma
Nonsmall Cell Lung Cancer
Solid Tumors

Interventions: Drug: Cisplatin
Drug: Gemcitabine
Drug: Talazoparib

First Posted Date: 2015-09-01

Last Posted Date: 2016-02-11

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02537561

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy